Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Furst

Showing results (11-20 of 477) with videos related to

Pageof 48
Sort By:
Annals of the New York Academy of Sciences|September 7, 2007
Measuring outcomes in PAH: the gap between the measures that are used and their validityDaniel E Furst
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 17, 2006
Postmarketing surveys: up sides and down sidesDaniel E Furst
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 27, 2012
Women are from venus, men are from Mars: do gender differences also apply to rheumatoid arthritis activity and treatment responses?Olga Morgacheva, Daniel E Furst
Current Opinion in Rheumatology|October 6, 2007
Adult stem cell treatment of sclerodermaAlan Tyndall, Daniel E Furst
European Journal of Epidemiology|November 12, 2005
Systemic sclerosis mortality in the United States: 1979-1998Eswar Krishnan, Daniel E Furst
Seminars in Arthritis and Rheumatism|April 10, 2012
Perspectives in Rheumatoid Abstracts from 2011 meeting selected proceedings of the 4(th) Annual Perspectives in Rheumatic Diseases 2011Daniel E Furst, Brian Mandell
Rheumatology (Oxford, England)|January 10, 2014
Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targetsDaniel E Furst, Paul Emery
The American Journal of Managed Care|April 17, 2008
Health-related quality of life in rheumatoid arthritisDaniel E Furst, Dinesh Khanna
Expert Opinion on Drug Safety|June 5, 2020
Safety of repository corticotropin injection as an adjunctive therapy for the treatment of rheumatoid arthritisRoy Fleischmann, Daniel E Furst
European Journal of Rheumatology|November 9, 2020
The burning question: To use or not to use cyclophosphamide in systemic sclerosisCosimo Bruni, Daniel E Furst
Pageof 48

Showing results (11-20 of 477) with videos related to

Sort By:
Pageof 48
Annals of the New York Academy of Sciences|September 7, 2007
Measuring outcomes in PAH: the gap between the measures that are used and their validityDaniel E Furst
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 17, 2006
Postmarketing surveys: up sides and down sidesDaniel E Furst
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 27, 2012
Women are from venus, men are from Mars: do gender differences also apply to rheumatoid arthritis activity and treatment responses?Olga Morgacheva, Daniel E Furst
Current Opinion in Rheumatology|October 6, 2007
Adult stem cell treatment of sclerodermaAlan Tyndall, Daniel E Furst
European Journal of Epidemiology|November 12, 2005
Systemic sclerosis mortality in the United States: 1979-1998Eswar Krishnan, Daniel E Furst
Seminars in Arthritis and Rheumatism|April 10, 2012
Perspectives in Rheumatoid Abstracts from 2011 meeting selected proceedings of the 4(th) Annual Perspectives in Rheumatic Diseases 2011Daniel E Furst, Brian Mandell
Rheumatology (Oxford, England)|January 10, 2014
Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targetsDaniel E Furst, Paul Emery
The American Journal of Managed Care|April 17, 2008
Health-related quality of life in rheumatoid arthritisDaniel E Furst, Dinesh Khanna
Expert Opinion on Drug Safety|June 5, 2020
Safety of repository corticotropin injection as an adjunctive therapy for the treatment of rheumatoid arthritisRoy Fleischmann, Daniel E Furst
European Journal of Rheumatology|November 9, 2020
The burning question: To use or not to use cyclophosphamide in systemic sclerosisCosimo Bruni, Daniel E Furst
Pageof 48